4Fine MJ, Auble TE, Yearly DM, et al. A prediction rule to identify low risk patients with community-acquired pneumonia. N Engl J Med, 1997,336 : 243 -250.
5Lim WS, van der Earden MM, laing R, et al. Defining community acquired pneumonia severity on presentation to hospital:an international derivation and validation study. Thorax,2003,58:377-382.
6Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med,2008,121:219-225.
7Menendez R, Cavalcanti M, Reyes, et al. Markers of treatment failure in hospitalized eommtmity acquired pneumonia. Thorax,2008,63:447-452.
8Bircan A, Kaya O, Gokirmak M, et al. C-reactive protein, leukocyte count and ESR in the assessment of severity of community-acquired pneumonia. Tuberk Toraks,2006,54 : 22-29.
9Kim GY, Park SY, Yoon HY, et al. Investigation of hemostatic changes in patients with sepsis. Korean J Lab Med,2007,27:157-161.
10Guneysel O, Pirmit S, Karakurt S. Plasma d-dimer levels increase with the severity of community acquired pneumonia. Tuberkuloz ve Toraks Dergisi, 2004,52 : 341-347.
